Cancer

Israeli prime minister says early-stage malignant tumour was discovered during a routine check-upMiddle East crisis – live updatesBenjamin Netanyahu has revealed that he received successful treatment for early-stage prostate cancer, without specifying when the treatment took place.In a statement on social media, as his annual medical report was released, the Israeli prime minister said an early-stage malignant tumour had been discovered during a routine checkup. The 76-year-old said targeted treatment had removed “the problem” and left no trace of it. Continue reading...

NHS struggling to cope with record numbers, which Cancer Research UK says puts progress on survival rates at riskThe number of people in the UK being diagnosed with cancer has reached a record high, with one person diagnosed every 80 seconds, a report reveals.Cancer Research UK found that more than 403,000 people were being diagnosed with the disease each year, largely due to a growing and ageing population, as people are more likely to develop cancer as they get older. Continue reading...

Physicians issue reminder to public after TV doctor and CMS chief relays president’s claim on Don Jr podcastDonald Trump defended his consumption of diet soda by suggesting it might help prevent cancer, according to recent comments shared by Mehmet Oz in an interview with Donald Trump Jr.The remarks have even prompted some doctors to remind the public that, no, diet soda will not do anything to prevent cancer. Continue reading...

Exclusive: Pre-chemotherapy tests previously did not look for gene variant that put some ethnicities at higher risk of serious side effectsThousands of cancer patients from minority ethnic backgrounds will have access to “groundbreaking” genetic testing on the NHS that previously discriminated against them.This routine form of genetic testing, used before chemotherapy treatment, could save the lives of Black and minority ethnic cancer patients who already face poorer health outcomes after diagnosis compared with their white counterparts. Continue reading...

PhenMap tool could spare thousands of patients from treatment that would be ineffective for themA new AI-driven way of identifying how patients with advanced bowel cancer will respond to a drug that was recently introduced by the NHS has been announced.Researchers at London’s Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have developed the method with the goal of sparing potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers. Continue reading...

Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drugGSK has revealed positive results for a treatment for gynaecological cancers as its chief executive, Luke Miels, steps up drug development efforts at the group.The company said that in an early-stage trial Mocertatug Rezetecan, known as Mo-Rez, shrank or eliminated tumours in 62% of patients with ovarian cancer where chemotherapy had failed, and in 67% of those with endometrial cancer. Continue reading...

Relacorilant, typically used to treat Cushing’s syndrome, could improve outcomes in platinum-resistant casesA drug originally used to treat a rare disease could extend the lives of patients with an aggressive form of ovarian cancer, according to a clinical trial.Platinum-resistant ovarian cancer occurs when the disease progresses within six months of starting platinum-based chemotherapy. This form of chemotherapy is different from other types because it uses compounds that contain platinum to destroy cancer cells by preventing them from dividing. Continue reading...